These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21224121)

  • 1. Efficacy of an echo contrast agent, SH/TA-508, in color doppler sonography of mass lesions in urology.
    Watanabe H; Saitoh M; Orikasa S; Matsushima M; Yoshida H; Tanahashi Y; Matsuo M; Watanabe M; Chiba Y; Sawamura TY; Saito T; Nonomura M
    Urol Oncol; 1995; 1(5):215-22. PubMed ID: 21224121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [SH/TA-508 clinical phase II study: dose evaluation of SH/TA-508 in echocardiography].
    Miyatake K; Yamaguchi T; Takatsuji H; Igarashi T; Nakamura K; Saeki F; Kato K; Suzuki M; Kamada T; Yamamoto K
    J Cardiol; 1995 Aug; 26(2):111-33. PubMed ID: 7674143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Echo-enhanced color Doppler sonography in children and adolescents.
    Riccabona M; Uggowitzer M; Klein E; Lindbichler F; Ebner F; Fotter R
    J Ultrasound Med; 2000 Nov; 19(11):789-96. PubMed ID: 11065268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-Enhanced Transcranial and Extracranial Duplex Sonography: Preliminary Results of a Multicenter Phase II/III Study with SonoVuetrade mark.
    Bogdahn U; Hölscher T; Rosin L; Götz B; Schlachetzki F
    Echocardiography; 1999 Oct; 16(7, Pt 2):761-766. PubMed ID: 11175220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of contrast-enhanced color Doppler ultrasonography for the diagnosis of renal mass lesions].
    Matsumoto S; Minami T; Yamamoto Y; Nishioka T; Akiyama T; Onoue A
    Hinyokika Kiyo; 2001 May; 47(5):299-302. PubMed ID: 11433747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SonoVue in transcranial Doppler investigations of the cerebral arteries.
    Kaps M; Legemate DA; Ries F; Ackerstaff RG; Markus H; Pezzoll C; Llull JB; Spinazzi A
    J Neuroimaging; 2001 Jul; 11(3):261-7. PubMed ID: 11462292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Color Doppler signal enhancement with SH/TH-508 in pancreatic tumors].
    Imai H; Horiguchi Y; Kubo H; Suzuki T; Sakamoto K; Uematsu M; Takeuchi F; Nakamura H; Hayashi T; Tokuda A; Asano M; Murai J; Osakabe K; Kushi Y; Nishikawa T; Sugita Y; Soeshima C
    Nihon Rinsho; 1998 Apr; 56(4):1018-23. PubMed ID: 9577627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new Doppler signal enhancing agent for flow assessment in breast lesions.
    Madjar H; Prömpeler HJ; Del Favero C; Hackelöer BJ; Llull JB
    Eur J Ultrasound; 2000 Dec; 12(2):123-30. PubMed ID: 11118919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Color Doppler flow imaging of renal disease. Value of a new intravenous contrast agent: SH U 508 A (Levovist).
    Filippone A; Muzi M; Basilico R; Di Giandomenico V; Trapani AR; Bonomo L
    Radiol Med; 1994 May; 87(5 Suppl 1):50-8. PubMed ID: 8209018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Power, spectral, and color flow Doppler enhancement by a new ultrasonographic contrast agent.
    Pugh CR; Arger PH; Sehgal CM
    J Ultrasound Med; 1996 Dec; 15(12):843-52. PubMed ID: 8947860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and clinical value of an intravenous echo-enhancement agent in evaluation of high-grade internal carotid stenosis.
    Sitzer M; Rose G; Fürst G; Siebler M; Steinmetz H
    J Neuroimaging; 1997 Apr; 7 Suppl 1():S22-5. PubMed ID: 9128462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contrast echo imaging on the breast and thyroid cancers].
    Kawauchi A; Hashimoto Y; Kamiya K; Hattori H; Kusano M
    Nihon Rinsho; 1998 Apr; 56(4):1049-54. PubMed ID: 9577633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of contrast-enhanced power Doppler sonography using a microbubble echo-enhancing agent in evaluation of small breast lesions.
    Kook SH; Kwag HJ
    J Clin Ultrasound; 2003 Jun; 31(5):227-38. PubMed ID: 12767017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Color Doppler imaging of liver metastases. The value phase-III of a US contrast agent: SH U 508 A (Levovist) Schering.
    Campani R; Bozzini A; Calliada F; Bottinelli O; Anguissola R; Conti MP; Corsi G
    Radiol Med; 1994 May; 87(5 Suppl 1):32-40. PubMed ID: 8209016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter, prospective, open label, randomized, controlled phase IIIb study of SH U 508 a (Levovist) for Doppler signal enhancement in the portal vascular system.
    Gebel M; Caselitz M; Bowen-Davies PE; Weber S
    Ultraschall Med; 1998 Aug; 19(4):148-56. PubMed ID: 9816618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Color Doppler enhancement with contrast agents for the detection of prostatic cancer].
    Watanabe M
    Nihon Rinsho; 1998 Apr; 56(4):1040-4. PubMed ID: 9577631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved sensitivity of color Doppler by SH U 454.
    Becher H; Schlief R
    Am J Cardiol; 1989 Aug; 64(5):374-7. PubMed ID: 2756883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the continuous infusion of Levovist on color Doppler sonography in portal hypertension.
    Schiedermaier P; Layer G; Sauerbruch T
    AJR Am J Roentgenol; 2002 Jan; 178(1):61-5. PubMed ID: 11756088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Levovist].
    Beppu S
    Nihon Rinsho; 1998 Apr; 56(4):876-80. PubMed ID: 9577601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [What is the role of Doppler color sonography associated with echo-signal enhancing levovist in complementary breast diagnosis?].
    Grüner C; Schönwälder A; Schulz-Wendtland R; Lang N; Bautz W
    Aktuelle Radiol; 1998 Mar; 8(2):58-62. PubMed ID: 9592578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.